Dr. Reddy’s Laboratories has launched Doxycycline Capsules, 40 mg, in the U.S. market.
A therapeutic generic equivalent of Swiss drugmaker Galderma Holdings’ Oracea (doxycycline, USP) Capsules, 40 mg, the product is a tetracycline-class drug. It is indicated for treatment of inflammatory lesions (papules and pustules) associated with rosacea in adult patients. The launch by Dr. Reddy’s follows U.S. Food and Drug Administration approval.
Disclaimer: The copyright of this article belongs to the original author. Reposting this article is solely for the purpose of information dissemination and does not constitute any investment advice. If there is any infringement, please contact us immediately. We will make corrections or deletions as necessary. Thank you.